The role of cardio-protective agents in cardio-preservation in breast cancer patients receiving Anthracyclines +/- Trastuzumab: a Meta-analysis of clinical studies

Overview

cited authors

Elghazawy, Hagar; Venkatesulu, Bhanu Prasad; Verma, Vivek; Pushparaji, Bala; Monlezun, Dominique J.; Marmagkiolis, Konstantinos; Iliescu, Cezar A.

Publication Date

September 1, 2020

webpage

Web of Science

published in

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY Journal

Research

keywords

Angiotensin converting enzyme inhibitor
Angiotensin receptor blocker
Beta-blocker
Breast cancer
Cardio-protection
Cardiotoxicity

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.